Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ketesse 50 mg/2 ml raztopina za injiciranje/infundiranje
menarini international o.l.s.a. - deksketoprofen - raztopina za injiciranje/infundiranje - deksketoprofen 25 mg / 1 ml - deksketoprofen
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
menadex 50 mg/2 ml raztopina za injiciranje/infundiranje
menarini international o.l.s.a. - deksketoprofen - raztopina za injiciranje/infundiranje - deksketoprofen 25 mg / 1 ml - deksketoprofen
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
menadex 50 mg/2 ml raztopina za injiciranje ali koncentrat za raztopino za infundiranje
menarini international o.l.s.a. - deksketoprofen - raztopina za injiciranje/infundiranje - deksketoprofen 25 mg / 1 ml - deksketoprofen
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
diclo duo 75 mg trde gastrorezistentne kapsule
pharmaswiss Česká republika s.r.o. - natrijev diklofenakat - gastrorezistentna kapsula, trda - natrijev diklofenakat 75 mg / 1 kapsula - diklofenak
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
novtirox 50 mikrogramov tablete
aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 50 µg / 1 tableta - natrijev levotiroksinat
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
novtirox 200 mikrogramov tablete
aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 200 mg / 1 tableta - natrijev levotiroksinat
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
novtirox 100 mikrogramov tablete
aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 100 mg / 1 tableta - natrijev levotiroksinat
Slovenia -
slovenă -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
novtirox 25 mikrogramov tablete
aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 25 mg / 1 tableta - natrijev levotiroksinat
Uniunea Europeană -
slovenă -
EMA (European Medicines Agency)
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - imunosupresivi - glejte poglavje 4. 1 povzetka glavnih značilnosti zdravila v dokumentu z informacijami o izdelku.
Uniunea Europeană -
slovenă -
EMA (European Medicines Agency)
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.